Cecilia Edström ♦️

Teint was born to bring products to the world that serve the 7+ billion people in it. Our skin tone adapted plasters are just the beginning of our journey to build a new inclusive industry of consumer products.

The commercially available Stockholm3- test, is a blood-test for early detection of prostate cancer. A3P Biomedical’s Stockholm3 test, combines protein markers, genetic markers and clinical data with an advanced algorithm in order to detect aggressive prostate cancer at early stage.

Perspetivo is a leading SaaS research company in Sweden offering representative Market research and data that mirrors the diverse perspectives and demographics in the Nordics, minority groups included. Perspetivo represents the diversity of people and perspectives in our society. By including everyone, we offer data and insights that mirrors the entire population. We provide reliable insights based on your needs and requirements, whether you’re addressing a wide audience or specific target groups. We believe in Asking Everyone. As a result of having representative data, we deliver accurate and trustworthy insights. Read about our services on www.perspetivo.com.

Teint was born to bring products to the world that serve the 7+ billion people in it. Our skin tone adapted plasters are just the beginning of our journey to build a new inclusive industry of consumer products.

Neonode Inc. (NASDAQ:NEON) is a publicly traded company, headquartered in Stockholm, Sweden and established in 2001. The company provides advanced optical sensing solutions for contactless touch, touch, gesture control, and in-cabin monitoring. Building on experience acquired during years of advanced R&D and technology licensing, Neonode’s technology is currently deployed in more than 75 million products and the company holds more than 120 patents worldwide. Neonode’s customer base includes some of the world’s best-known Fortune 500 companies in the consumer electronics, office equipment, medical, avionics, and automotive industries. NEONODE and the NEONODE logo are trademarks of Neonode Inc. registered in the United States and other countries. For further information please visit www.neonode.com

The commercially available Stockholm3- test, is a blood-test for early detection of prostate cancer. A3P Biomedical’s Stockholm3 test, combines protein markers, genetic markers and clinical data with an advanced algorithm in order to detect aggressive prostate cancer at early stage.

BE Group is a leading independent steel distributor that stores and processes steel, stainless steel, and aluminium for customers primarily in the construction and manufacturing industries. Through the companys production services, customers can order customized steel components to optimize their production processes. The companys largest markets are Sweden and Finland. The headquarters is located in Malmö.